CDC801 is a novel, potent and orally bioavailable inhibitor of phosphodiesterase 4 (PDE4) and tumor necrosis factor-α (TNF-α) with IC50 of 1.1 μM and 2.5 μM, respectively.

纯度：≥98%

CAS：192819-27-5